Patent Approval: Minitab has received a Notice of Allowance from the USPTO for its innovative statistical method aimed at correcting and analyzing low-resolution measurement data, thereby enhancing the accuracy of distribution testing, particularly for normally-distributed data.
Addressing Manufacturing Challenges: This method introduces controlled variation to resolve issues where goodness-of-fit tests fail due to insufficient measurement precision or data discreteness, significantly reducing the risk of false rejections and ensuring accurate assessments of product reliability and process capability.
Broad Application Potential: The new method is applicable across various industries, including manufacturing, medical device development, and digital analytics, enabling accurate recovery of true data distributions without the need for new measurement tools, thus enhancing statistical decision-making.
Industry Impact: Minitab's innovation will empower engineers and analysts to make more reliable decisions when faced with low-resolution data, meet regulatory requirements, and protect customer interests, further solidifying its leadership position in the data analytics field.
MTB
$206.56+Infinity%1D
Analyst Views on MTB
Wall Street analysts forecast MTB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MTB is 220.90 USD with a low forecast of 185.00 USD and a high forecast of 251.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
Wall Street analysts forecast MTB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MTB is 220.90 USD with a low forecast of 185.00 USD and a high forecast of 251.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
7 Hold
1 Sell
Moderate Buy
Current: 204.090
Low
185.00
Averages
220.90
High
251.00
Current: 204.090
Low
185.00
Averages
220.90
High
251.00
Truist
Brian Foran
Buy -> Hold
downgrade
$217
2025-12-12
New
Reason
Truist
Brian Foran
Price Target
$217
2025-12-12
New
downgrade
Buy -> Hold
Reason
Truist analyst Brian Foran downgraded M&T Bank to Hold from Buy with an unchanged price target of $217. The company's excess capital position is now less of a differentiator versus peers as more regional banks "tip into an excess position," the analyst tells investors in a research note. Truist cites valuation for the downgrade of M&T, saying investors should lock in profits at current share levels.
TD Cowen
Steven Alexopoulos
Buy
maintain
$235 -> $245
2025-10-20
Reason
TD Cowen
Steven Alexopoulos
Price Target
$235 -> $245
2025-10-20
maintain
Buy
Reason
TD Cowen analyst Steven Alexopoulos raised the firm's price target on M&T Bank to $245 from $235 and keeps a Buy rating on the shares. The firm updated its model following solid Q3 results coupled with renewed momentum in commercial lending and steady core fundamentals.
Truist
Buy
maintain
$227 -> $217
2025-10-17
Reason
Truist
Price Target
$227 -> $217
2025-10-17
maintain
Buy
Reason
Truist lowered the firm's price target on M&T Bank to $217 from $227 and keeps a Buy rating on the shares as part of a broader research note on Regional Banks / Consumer Finance names. The firm is updating its models following their Q3 results and updated guidance, noting the companies' expectations for higher net interest margins and growth in core lending rates, but also citing the sector re-rating down from broader credit concerns, the analyst tells investors in a research note.
Evercore ISI
John Pancari
Outperform
maintain
$222 -> $225
2025-09-30
Reason
Evercore ISI
John Pancari
Price Target
$222 -> $225
2025-09-30
maintain
Outperform
Reason
Evercore ISI analyst John Pancari raised the firm's price target on M&T Bank to $225 from $222 and keeps an Outperform rating on the shares. Regional bank and specialty finance trends "appear solid" for Q3, but full momentum in earnings might not be seen until early 2026, the analyst tells investors in a preview for the group.
About MTB
M&T Bank Corporation is a financial holding company. The Company’s principal banking subsidiary, M&T Bank, provides banking products and services with a branch and ATM network spanning the eastern United States from Maine to Virginia and Washington, D.C. Trust-related services are provided in select markets in the United States and abroad by its Wilmington Trust-affiliated companies and by M&T Bank. Its segments include Commercial Bank, Retail Bank and Institutional Services and Wealth Management. The Commercial Bank segment provides a range of credit products and banking services to middle-market and large commercial customers, mainly within the markets served by the Company. The Retail Bank segment provides a wide range of services to consumers and small businesses through the Company’s branch network and several other delivery channels. The Institutional Services and Wealth Management segment provides a variety of trustee, agency, investment management and administrative services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
